Hi-Yield T7 In Vitro Transcription Reagent (pUTP)
Hi-Yield T7 In Vitro Transcription Reagent (pUTP)

  • 453
  • 454
50T
HBP001506

Cat. No: HBP001506

Transportation and storage: Transportation under 0°C and storage at -25~ -15°C.

Technical Support

Product Overview


Hi-yield T7 in vitro transcription reagent kit is designed for in vitro transcription of RNA using T7 RNA polymerase. The kit is capable of synthesizing high yield RNA transcripts using linear double-stranded DNA containing T7 promoter as template and NTPs as substrate.


The kit is suitable for incorporation of modified nucleotides to obtain biotin labeled, dye labeled and radiolabeled RNA. The kit also can be applied in synthesis of co-transcriptionally capping mRNAs with cap analogs. The kit contains modified nucleotides pUTP as alternative.


Each standard reaction yields up to 150-200 μg of RNA from 1μg DNA template. Reaction size can be scaled up to yield milligram-level RNA as needed.


RNA synthesized from the kit is suitable for many applications including RNA structure and function studies, ribozyme biochemistry, RNase protection assays and hybridization-based blots, anti-sense RNA and RNAi experiment.


RNA synthesized from the kit also is suitable for enzymatic production of capped RNA by vaccinia capping enzyme (HBP000606) and 2’-O-Methyltransferase (HBP000701), and for polyadenylation with Poly(A) polymerase (HBP000801) to improve the stability and translational competence of RNA used for in vitro translation, transfection, and microinjection.



Key Features


High-Yield RNA Synthesis


Generates up to 180-220 μg of RNA from 1 μg of DNA template under standard reaction conditions, enabling efficient RNA production and scalable manufacturing.


Superior Transcript Integrity


Powered by an engineered high-specific-activity T7 RNA Polymerase, the kit minimizes transcriptional side reactions and delivers RNA transcripts with excellent integrity and reproducibility.


Optimized for pUTP Incorporation


Compatible with pUTP and a broad range of modified nucleotides, enabling the synthesis of modified RNAs for diverse research and therapeutic applications.


Broad Compatibility


Supports the use of various cap analogs and co-transcriptional capping strategies, providing flexibility for different IVT workflows.


Flexible Template Support


Efficiently transcribes templates ranging from 200 bp to 12 kb, accommodating RNA products of varying lengths and complexities.


Complete, Ready-to-Use IVT Workflows


Supplied as a pre-optimized kit containing all essential reagents, eliminating manual formulation and reducing workflow setup time.



Applications


Modified RNA Production


Supports the incorporation of pUTP during IVT, enabling the generation of modified RNA transcripts for a variety of downstream applications.


mRNA Vaccine and Therapeutic Development


Suitable for the production of high-quality RNA for mRNA vaccine research, gene therapy development, and other RNA-based therapeutics.


High-Quality IVT Workflows


The kit incorporates an engineered high-specific-activity T7 RNA Polymerase mutant (Cat. No. HBP000330) to improve transcription efficiency, reduce undesired side reactions, and enhance both RNA yield and transcript integrity.


Streamlined Workflow Development


As a complete, pre-optimized transcription system, the kit minimizes reaction setup and optimization efforts, enabling users to rapidly obtain reproducible IVT products with high efficiency.



Performance Data


Yield Comparison & Integrity Comparison




dsRNA Content Comparison



Performance on Different Length Templates







Component List

Component Concentration Volume
ATP 100 mM 100 μL
CTP 100 mM 100 μL
GTP 100 mM 100 μL
UTP 100 mM 100 μL
pUTP 100 mM 100 μL
10 × Hi-Yield IVT Buffer A / 100 μL
10 × Hi-Yield IVT Buffer B / 100 μL
Enzyme Mix / 100 μL
Control template 1 0.5 μg/μL 10 μL
LiCl 5 M 1.4 mL
DNase I 5 U/μL 100 μL


FAQ


Is this kit compatible with pUTP incorporation?


Yes. The kit supports the incorporation of pUTP and other modified nucleotides during in vitro transcription, enabling the synthesis of modified RNA for a variety of downstream applications.


What RNA yield can be achieved with this kit?


Under standard reaction conditions, the kit can generate up to 150-200 μg of RNA from 1 μg of DNA template. The reaction can also be scaled up to produce milligram quantities of RNA.

Please update the value if the final specification is 180-220 μg.


Is the kit compatible with cap analogs?


Yes. The kit supports co-transcriptional capping using cap analogs, allowing the generation of capped RNA transcripts.


What applications is this kit suitable for?


The kit is suitable for modified RNA production, mRNA vaccine research, gene therapy development, RNA labeling studies, and other applications requiring high-yield IVT products.


How should the kit be stored and transported?


The kit should be transported below 0°C and stored at -25 to -15°C to maintain optimal stability and performance.

Message
Order Inquiry
Name *
Company *
Position *
Tel *
Mail *
Nation *

Do you have purchasing intention??

Requirement Description

Please contact on WhatsApp

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

  • iso_copy_copy
  • iso_copy
  • iso
  • iso_copy_copy
  • iso_copy
  • iso
Contact Us

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |